Article
Cost-Utility and Cost-Effectiveness Analysis of disease-modifying drugs of Relapsing-Remitting Multiple Sclerosis: A Systematic Review
2022-08-12
Abstract excerpt
<h4>Background</h4> Multiple sclerosis is a chronic demyelinating disorder of the central nervous system that is categorized as an immune-mediated inflammatory disease. This study aimed to systematically review the cost-benefit and cost-effectiveness of relapsing-remitting drugs for multiple sclerosis. <h4>Methods</h4> To find related research and articles, articles published in Iranian and international databases...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 956dd18f-ddb1-5358-9cb9-389724b51d58
- DOI
- 10.1101/2022.08.10.22278518
